SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Sunshine Biopharma Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.24+0.02 (+9.02%)
Close on Oct 19, 2026
- Market cap
- $330.14K
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jun 1, 2026 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Aug 8, 2024 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| May 20, 2024(first seen in filings) | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Apr 17, 2024 | 1-for-100 reverse | Earlier per-share figures multiplied by 100 |
| Mar 21, 2022(first seen in filings) | 1-for-200 reverse | Earlier per-share figures multiplied by 200 |
| May 1, 2020(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Apr 12, 2019(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |